Page last updated: 2024-08-18

1-naphthylamine and HIV Infections

1-naphthylamine has been researched along with HIV Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rabkin, JG; Rabkin, R; Wagner, G1
Charness, WE; Ferrando, SJ; Goldman, JD1

Trials

2 trial(s) available for 1-naphthylamine and HIV Infections

ArticleYear
Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:10

    Topics: 1-Naphthylamine; Affect; Antidepressive Agents; CD4 Lymphocyte Count; Comorbidity; Depressive Disorder; Female; HIV Infections; Humans; Immunity; Killer Cells, Natural; Leukocyte Count; Male; Psychiatric Status Rating Scales; Sertraline; T-Lymphocyte Subsets; T-Lymphocytes; Treatment Outcome

1994
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
    General hospital psychiatry, 1997, Volume: 19, Issue:2

    Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders

1997